Allkem General Discussion, page-2442

Good morning to Australia!

It's still a little early for us, actually still night, which was short again for me, but with rising prices that's ok.

Albemarle has revised up earnings expectations for 2022. In addition, there is an analyst assessment, which is evident in the EPS. "Diluted EPS of $19.25 to $22.25 vs. previous guidance of $12.30 to $15.00"

Because Albemarle has a wide range of products and not only
produces lithium, I did a bit of a search
because of the forecasts for Allkem.

Here is a forecast that does not refer to the course:
With the previous sales estimates, the analysts were not that bad: for 2022, they predicted 1.1 billion AUD$ 1.12 billion
But how does it look for 2023 and the following years :
Sales = 2023 -- 2.13 billion / 2024 -- 2.97 billion / 2025 -- 3.48 billion / 2026 -- 4.06 billion

This means that EPS will increase by almost 400% from 2022 to 2026.
How is this called? A cash cow!!!